Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
AbstractMigraine is the most common neurological disorder, and contributes to disability and large healthcare costs in the United States and the world. The treatment of migraine until recently has focused on medications, both abortive and prophylactic, but treatment of chronic migraine has been revolutionized with the introduction of botulinum toxin injection therapy. In this review, we explore the current understanding of migraine pathophysiology, and the evolution of the use of botulinum toxin therapy including proposed pathophysiological mechanisms through animal data. We also discuss the similarities and differences between three injection techniques. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Schaefer, S.M.; Gottschalk, C.H.; Jabbari, B. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins. Toxins 2015, 7, 2615-2628.
Schaefer SM, Gottschalk CH, Jabbari B. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins. Toxins. 2015; 7(7):2615-2628.Chicago/Turabian Style
Schaefer, Sara M.; Gottschalk, Christopher H.; Jabbari, Bahman. 2015. "Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins." Toxins 7, no. 7: 2615-2628.